018510899

DEMMUNIZATION

---

July 7, 2021

Trademark Summary

The trademark application DEMMUNIZATION was filed by CANOPY IMMUNO-THERAPEUTICS LTD, a corporation established under the laws of the State of Israel (the "Applicant"). The application was published for oppositions on August 11, 2021, and it was registered by office on November 18, 2021 without any oppositions.

The application was filed in English (German was selected as the second language).

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Pharmaceutical preparations and substances for the treatment of autoimmune, allergic and inflammatory diseases and disorders
  2. Pharmaceutical preparations and substances for the treatment of autoimmune, allergic and inflammatory diseases by eliminating specific lymphocytes lineages or modulating the immune response using a variety of organic compounds and recombinant proteins
  3. Pharmaceutical preparations and substances that modulate the immune system by recombinant proteins that contain a targeting moiety and an effector moiety to eliminate specific lymphocytes lineages and attenuate or block the antibody creation and antigen specific immune response in autoimmune, Allergic and inflammatory diseases
  4. Pharmaceutical preparations and substances that modulate the immune system by recombinant proteins that contain a targeting moiety and an effector moiety to eliminate specific lymphocytes lineages and attenuate or block the creation of the antibodies IgG, IgE or IgA and antigen specific immune response in autoimmune, allergic and inflammatory diseases
  5. Pharmaceutical preparations and substances with potential immunomodulation activity to treat under and over responsiveness of the immune system.